Skip to main content
Clinical Trials/NCT06329284
NCT06329284
Completed
Not Applicable

Midkine Interplays With Oxidative Stress and Inflammatory Milieu to Induce Preeclampsia in Normotensive Pregnant Women

Benha University1 site in 1 country80 target enrollmentJanuary 1, 2023
ConditionsPre-Eclampsia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pre-Eclampsia
Sponsor
Benha University
Enrollment
80
Locations
1
Primary Endpoint
Severity of Pre-Eclampsia (PE)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Preeclampsia (PE) is a hypertensive pregnancy-related disorder that endangers maternal and fetal outcomes and accounts for 9-10% of maternal mortalities with its early-onset phenotype is the most dangerous, but its etiology is still not fully elucidated.

Midkine (MDK) is a multifunctional protein that plays a unique role in the development of hypertension (HTN), via its proatherogenic effect and induction of overexpression of angiotensin converting enzyme. Oxidative stress (OS) upregulates the expression of MDK and MDK induces propagation of neoangiogenesis and acts as chemotactic for neutrophils.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
December 15, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shereen Naguib

Lecturer of Obstetrics & Gynecology, Faculty of Medicine

Benha University

Eligibility Criteria

Inclusion Criteria

  • Newly pregnant normotensive (NT) women with singleton fetus;
  • Free of the Exclusion Criteria.

Exclusion Criteria

  • Women with history of complicated pregnancy;
  • Had manifest essential hypertension, Diabetes Mellitus or chronic kidney diseases;
  • Had multiple gestational sacs, morbid obesity with Body Mass Index at time of pregnancy diagnosis over 35 kg/m2;
  • Had genetic disorders, coagulopathy, autoimmune diseases or maintained on immunosuppressive therapy.

Outcomes

Primary Outcomes

Severity of Pre-Eclampsia (PE)

Time Frame: 8 months

Correlation between Serum midkine levels and blood pressure measurements

Study Sites (1)

Loading locations...

Similar Trials